Abbott India Ltd vs Procter Gamble Health Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 07, 2026

Key Highlights

The Latest Trading Price of Abbott India Ltd is ₹ 26692 as of 07 May 15:30 . The P/E Ratio of Abbott India Ltd changed from 46.1 on March 2021 to 0 on June 2024 . This represents a CAGR of -100.00% over 9 yearsThe P/E Ratio of Procter & Gamble Health Ltd changed from 27.3 on March 2025 to 41.7 on June 2024 . This represents a CAGR of 8.84% over 5 years The Market Cap of Abbott India Ltd changed from ₹ 31850 crore on March 2021 to ₹ 0 crore on June 2024 . This represents a CAGR of -100.00% over 9 yearsThe Market Cap of Procter & Gamble Health Ltd changed from ₹ 8535 crore on March 2025 to ₹ 8382 crore on June 2024 . This represents a CAGR of -0.36% over 5 years The revenue of Abbott India Ltd for the Mar '25 is ₹ 1680 crore as compare to the Sep '25 revenue of ₹ 1827 crore. This represent the decline of -8.02% The revenue of Procter & Gamble Health Ltd for the Mar '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 329.87 crore. This represent the decline of -100% The ebitda of Abbott India Ltd for the Mar '25 is ₹ 504.56 crore as compare to the Sep '25 ebitda of ₹ 572.12 crore. This represent the decline of -11.81% The ebitda of Procter & Gamble Health Ltd for the Mar '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 125.22 crore. This represent the decline of -100% The net profit of Abbott India Ltd changed from ₹ 328.01 crore to ₹ 367.04 crore over 7 quarters. This represents a CAGR of 6.64% The net profit of Procter & Gamble Health Ltd changed from ₹ 82.33 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of -100.00% The Dividend Payout of Abbott India Ltd changed from 84.61 % on March 2021 to 0 % on June 2024 . This represents a CAGR of -100.00% over 9 yearsThe Dividend Payout of Procter & Gamble Health Ltd changed from 88.52 % on March 2025 to 214.75 % on June 2024 . This represents a CAGR of 19.39% over 5 years .

About Abbott India Ltd

Abbott India Ltd Share Price Overview Abbott India Ltd share price history records the movement of the stock in various phases of the market.
Company developments, as well as the general trends in the pharmaceutical industry, have influenced this movement.
As a healthcare-oriented company, the stock tends to respond to fluctuations in the demand of drugs, regulatory activities, and the general mood of investors.
The past performance of the stock gives the investors an idea of how it has reacted to the change in earnings, product portfolio development, and significant company occurrences at various times. Long-Term Performance The stock price performance of Abbott India Ltd has seen phases of fluctuation over time, with a 18% CAGR over the last 10 years.
This reflects movement across different market conditions, with periods of strength and correction.

About Procter & Gamble Health Ltd

Procter & Gamble Health Limited was erstwhile incorporated as E Merck (India) Limited in 1967.
The Company's name was changed from E Merck (India) Limited to Merck Limited on March 27, 2002.
Later, the name of the Company was changed to Procter & Gamble Health Limited on 6 May, 2019.
The company was set up to take over the business of the Indian branch of Emeda Exports with all their assets and liabilities.
The company is a 51% subsidiary of German firm Merck KGaA, is a leading player in vitamin formulations. Procter & Gamble Health Limited is an Indian-based company principally engaged in the business of manufacturing and marketing of pharmaceuticals and chemicals.

FAQs for the comparison of Abbott India Ltd and Procter & Gamble Health Ltd

Which company has a larger market capitalization, Abbott India Ltd or Procter & Gamble Health Ltd?

Market cap of Abbott India Ltd is 56,720 Cr while Market cap of Procter & Gamble Health Ltd is 8,821 Cr

What are the key factors driving the stock performance of Abbott India Ltd and Procter & Gamble Health Ltd?

The stock performance of Abbott India Ltd and Procter & Gamble Health Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Abbott India Ltd and Procter & Gamble Health Ltd?

As of May 7, 2026, the Abbott India Ltd stock price is INR ₹26692.15. On the other hand, Procter & Gamble Health Ltd stock price is INR ₹5314.25.

How do dividend payouts of Abbott India Ltd and Procter & Gamble Health Ltd compare?

To compare the dividend payouts of Abbott India Ltd and Procter & Gamble Health Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.